• Carlson, G.P., Ocen, P.O. and Harrold, D. (1976) Clinicopathologic alterations in normal and exhausted endurance horses. Theriogenol. 6, 93-104.
  • Cywinska, A., Gorecka, R., Szarska, E., Witkowski, L., Dziekan, P., Wyszynska, Z. and Schollenberger, A. (2008) The Effect of endurance ride on serum concentration of haptoglobin and serum amyloid A in horses. XIII Congress of Polish Society of Experimental and Clinical Immunology. Krakow 2008. Centr. Eur. J. Immunol. 33 (I), 169.
  • Eckersall, P.D. (2000) Recent advances and future prospects for the use of acute phase proteins as markers of disease in animals. Vet. Med. Rev. 151, 577-584.
  • Fallon, K.E. (2001) The acute phase response and exercise: the ultramarathon as prototype exercise. Clin. J. Sport Med. 11, 38-43.
  • Feldman, B.F., Zinkl, J.G. and Jain, N.C. (2000) Schalm's Veterinary Hematology, 5th edn., Lippincott Wiliams & Wilkins, Philadephia.
  • Fielding, C.L., Magdesian, K.G., Rhodes, D.M., Meier, C.A. and Higgins, J.C. (2009) Clinical and biochemical abnormalities in endurance horses eliminated from competition for medical complications and requiring emergency medical treatment: 30 cases (2005–2006). J. vet. emerg. crit. Care 19, 473-478.
  • Gruys, E., Toussaint, M.J.M., Niewold, T.A. and Koopmans, S.J. (2005) Acute phase reaction and acute phase proteins. J. Zhejiang Univ. SCI. 11, 1045-1056.
  • Heegaard, P.M.H. (2000) Akut-fase protein responset og dets brug som klinisk parameter. Dansk Vet. 19, 6-14.
  • Hinchcliff, H., Kaneps, A. and Geor, R. (2004) Equine Sports Medicine and Surgery, W.B. Saunders, Edinburgh, New York.
  • Hobo, S., Niwa, H. and Anzai, T. (2007) Evaluation of serum amyloid A and surfactant protein D in sera for identification of the clinical condition of horses with bacterial pneumonia. J. vet. med. Sci. 69, 827-830.
  • Hulten, C. and Demmers, S. (2002) Serum amyloid A (SAA) as an aid in the management of infectious disease in foal: comparison with total leukocyte count, neutrophil count and fibrinogen. Equine vet. J. 34, 693-698.
  • Hulten, C., Tulamo, R.M., Suominen, M.M., Burvaqll, K., Marhaug, G. and Forsberg, M. (1999a) A noncompetitive chemiluminescence enzyme immunoassay for the equine acute phase protein serum amyloid A (SAA) - a clinically useful inflammatory marker in the horse. Vet. Immunol. Immunopathol. 68, 267-281.
  • Hulten, C., Sandgren, B., Skioldebrand, E., Klingeborn, B., Marhaug, G. and Forsberg, M. (1999b) The acute phase protein serum amyloid A (SAA) as an inflammatory marker in equine Influenza Virus infection. Acta vet. Scand. 40, 33-333.
  • Jacobsen, S., Kjelgaard-Hansen, M., Hagbard Petersen, H. and Jensen, A.L. (2006) Evaluation of a commercially available human serum amyloid A (SAA) turbidometric imunoassay for determination of equine SAA concentrations. Vet. J. 172, 315-319.
  • Marlin, D. and Nankervis, K. (2002) Equine Exercise Physiology, Blackwell Science Ltd, Oxford.
  • Pepys, M.B., Baltz, M.L. and Tennent, G.A. (1989) Serum amyloid A protein (SAA) in horses: objective measurement of the acute phase response. Equine vet. J. 21, 106-109.
  • Petersen, H.H., Nielsen, J.P. and Heegaard, P.M.H. (2004) Application of acute phase protein measurements in veterinary clinical chemistry. Vet. Res. 35, 163-187.
  • Pollock, P.J., Prendergast, M., Schumacher, J. and Bellenger, C.R. (2005) Effects of surgery on the acute phase response in clinically normal and diseased horses. Vet. Rec. 156, 538-542.
  • Rossdale & Partners Veterinary Surgeons (2010) Beaufort Cottage Laboratories reference ranges. Available at: (accessed 30 July 2010).
  • Szarska, E. (2003) Investigations of blood parameters for evaluating of health status and training effects in race and sport horses. Zesz. Nauk. AR Wroclaw. 471, 1-115.